Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

3 terminated/withdrawn out of 6 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06860867Not ApplicableRecruiting

PerQdisc Traditional Feasibility Trial.

Role: lead

NCT05508360Not ApplicableRecruiting

"Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2)

Role: lead

NCT05732818Not ApplicableSuspended

Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy 3

Role: lead

NCT04141098Not ApplicableTerminated

Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy

Role: lead

NCT04004156Not ApplicableTerminated

Safety Study for An Artificial Disc Nucleus Replacement to Treat Chronic Low Back Pain

Role: lead

NCT05105490Withdrawn

Post Market Observational Trial for the PerQdisc Nucleus Replacement Device

Role: lead

All 6 trials loaded